-+ 0.00%
-+ 0.00%
-+ 0.00%

AGC Biologics Secures Three Cell Therapy Projects at Yokohama Site

PUBT·11/17/2026 00:01:01
Listen to the news
AGC Biologics Secures Three Cell Therapy Projects at Yokohama Site
  • AGC Biologics secured three cell therapy projects for its Yokohama site, including an Institute of Science Tokyo research program.
  • The institute's program targets treatment-resistant adenovirus infections following hematopoietic cell transplantation using third-party virus-specific T cells.
  • Yokohama supports the program through process development and analytical method development to facilitate future clinical use and manufacturing.
  • One customer program will transfer from Milan to Yokohama for future development and manufacturing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AGC Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611161900PRIMZONEFULLFEED9877883) on November 17, 2026, and is solely responsible for the information contained therein.